Correlation Between Prime Dividend and Big Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Prime Dividend and Big Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Prime Dividend and Big Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Prime Dividend Corp and Big Pharma Split, you can compare the effects of market volatilities on Prime Dividend and Big Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Prime Dividend with a short position of Big Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Prime Dividend and Big Pharma.

Diversification Opportunities for Prime Dividend and Big Pharma

-0.25
  Correlation Coefficient

Very good diversification

The 3 months correlation between Prime and Big is -0.25. Overlapping area represents the amount of risk that can be diversified away by holding Prime Dividend Corp and Big Pharma Split in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Big Pharma Split and Prime Dividend is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Prime Dividend Corp are associated (or correlated) with Big Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Big Pharma Split has no effect on the direction of Prime Dividend i.e., Prime Dividend and Big Pharma go up and down completely randomly.

Pair Corralation between Prime Dividend and Big Pharma

Assuming the 90 days trading horizon Prime Dividend Corp is expected to under-perform the Big Pharma. In addition to that, Prime Dividend is 4.65 times more volatile than Big Pharma Split. It trades about -0.11 of its total potential returns per unit of risk. Big Pharma Split is currently generating about -0.16 per unit of volatility. If you would invest  1,326  in Big Pharma Split on November 3, 2024 and sell it today you would lose (26.00) from holding Big Pharma Split or give up 1.96% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Prime Dividend Corp  vs.  Big Pharma Split

 Performance 
       Timeline  
Prime Dividend Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Prime Dividend Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Prime Dividend is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.
Big Pharma Split 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Big Pharma Split has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy primary indicators, Big Pharma is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Prime Dividend and Big Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Prime Dividend and Big Pharma

The main advantage of trading using opposite Prime Dividend and Big Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Prime Dividend position performs unexpectedly, Big Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Big Pharma will offset losses from the drop in Big Pharma's long position.
The idea behind Prime Dividend Corp and Big Pharma Split pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Other Complementary Tools

Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Stocks Directory
Find actively traded stocks across global markets